When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBRX - Moleculin Bio updates on annamycin development
Moleculin Biotech Inc.
Moleculin Biotech (NASDAQ:MBRX) announces an update on its clinical development plan for Annamycin, for the treatment of relapsed or refractory acute myeloid leukemia (AML).
More news on: Moleculin Biotech, Inc., Healthcare stocks news,